Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,883 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient-reported outcomes from a randomized, double-blind, placebo controlled, phase III study of baricitinib versus placebo in patients with moderately to severely active rheumatoid arthritis and an inadequate response to methotrexate therapy: results from the RA-BALANCE study.
Yang Y, Xu J, Xu J, Li X, Hu J, Li X, Zhang X, He D, Bao C, Li Z, Wang G, Zerbini CAF, Spindler AJ, Kannowski CL, Wu H, Ji F, Zhan L, Liu M, Li Z. Yang Y, et al. Among authors: he d. Ther Adv Musculoskelet Dis. 2021 Apr 20;13:1759720X211006964. doi: 10.1177/1759720X211006964. eCollection 2021. Ther Adv Musculoskelet Dis. 2021. PMID: 33959198 Free PMC article.
[Efficacy and safety of infliximab in patients with rheumatoid arthritis].
Zhang W, Shi Q, Wu DH, Bao CD, Yang NP, Li ZG, Zhu P, Zhang X, Huang CB, He DY, Ye ZZ, Tao Y, Fang YF, Gu JR, Wu HX, Sun LY, Yang XY, Huang F, Xu HJ, Zhao DB, Zhang MJ, Zheng Y, Ai MX, Lu J, Zhang FC. Zhang W, et al. Zhonghua Yi Xue Za Zhi. 2009 Jul 21;89(27):1876-80. Zhonghua Yi Xue Za Zhi. 2009. PMID: 19953907 Clinical Trial. Chinese.
Remission assessment of rheumatoid arthritis in daily practice in China: a cross-sectional observational study.
Zhu H, Li R, Da Z, Bi L, Li X, Li Y, Liu C, Zhang F, Li Z, Liu X, Zhang Z, Sun L, Wang Y, Zhang W, Jiang Q, Chen J, Chen Q, Li Z, Wu L, Qi W, Xu J, Cui X, Wang X, Li L, Leng X, Wang G, Zhao D, Jiang L, He D, Liu X, Li L, Fang Y, Huang C, Wu H, Hu S, Li Q, Song H, Xiao W, Gong L, Zhang L, Li X, Li Z, Su Y. Zhu H, et al. Among authors: he d. Clin Rheumatol. 2018 Mar;37(3):597-605. doi: 10.1007/s10067-017-3850-z. Epub 2017 Nov 7. Clin Rheumatol. 2018. PMID: 29116543
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study.
Bi L, Li Y, He L, Xu H, Jiang Z, Wang Y, Li X, Wei W, Gu J, Wang G, Zhang Z, Zhou B, Liu Y, Wu Z, Liu H, He D, Lv Z, Li Z, Zuo X, Dong L, Wu H, Zhang H, Chen H, Bao C, Zhang Z, Zhang M, Song H, Zheng Y, Jiang L, Liu X, Boehnlein M, Dunkel J, Shao J, Harris K, Li Z. Bi L, et al. Among authors: he d, he l. Clin Exp Rheumatol. 2019 Mar-Apr;37(2):227-234. Epub 2018 Aug 29. Clin Exp Rheumatol. 2019. PMID: 30183595 Free article. Clinical Trial.
Anti-cyclic citrullinated peptide antibody predicts the development of rheumatoid arthritis in patients with undifferentiated arthritis.
Li C, Zhang Y, Song H, Gao J, Zhao DB, Zhu Q, He DY, Wang L, Li XP, Liu XD, Xiao WG, Wu XY, Wu HX, Tu W, Hu SX, Wang X, Li ZJ, Lu ZM, Da ZY, Liang B, Liu XM, Zhao JW, Li L, Han F, Qi WF, Wei W, Ma X, Li ZB, Zheng GM, Zhang FX, Li Y, Wang YL, Ling GH, Chen JW, Hou XQ, Zhang J, Chen QP, Liu CL, Zhang Y, Zeng JS, Zou QH, Fang YF, Su Y, Li ZG. Li C, et al. Chin Med J (Engl). 2019 Dec 20;132(24):2899-2904. doi: 10.1097/CM9.0000000000000570. Chin Med J (Engl). 2019. PMID: 31855969 Free PMC article.
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial.
Su J, Li M, He L, Zhao D, Wan W, Liu Y, Xu J, Xu J, Liu H, Jiang L, Wu H, Zuo X, Huang C, Liu X, Li F, Zhang Z, Liu X, Dong L, Li T, Chen H, Li J, He D, Lu X, Huang A, Tao Y, Wang Y, Zhang Z, Wei W, Li X, Zeng X. Su J, et al. Among authors: he d, he l. BioDrugs. 2020 Jun;34(3):381-393. doi: 10.1007/s40259-020-00408-z. BioDrugs. 2020. PMID: 32078145 Free PMC article. Clinical Trial.
6,883 results